Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Puma Biotechnology, Inc. (PBYI) had Free Cash Flow of $15.42M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$44.81M |
|
$-3.75M |
|
$10.42M |
|
$34.39M |
|
$48.64M |
|
$-3.83M |
|
$0.40M |
|
$-3.43M |
|
$-3.43M |
|
$-3.75M |
|
$-3.75M |
|
$-3.75M |
|
$-3.75M |
|
$-3.83M |
|
$-1.24M |
|
50.84M |
|
50.84M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$142.26M |
|
$0.12M |
|
$50.44M |
|
$192.70M |
|
$59.74M |
|
-- |
|
$4.55M |
|
$64.28M |
|
$128.42M |
|
$89.46M |
|
$128.42M |
|
50.88M |
|
| Cash Flow Statement Financials | |
$15.42M |
|
$2.47M |
|
$-11.33M |
|
$31.73M |
|
$38.28M |
|
$6.56M |
|
$1.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
76.74% |
|
-8.54% |
|
-8.54% |
|
-- |
|
-7.65% |
|
-8.37% |
|
|
Free Cash Flow |
$15.42M |
-- |
|
-- |
|
-- |
|
0.23 |
|
1.20 |
|
1.70 |
|
52.88 |
|
-2.92% |
|
-4.20% |
|
-1.95% |
|
-2.92% |
|
$2.52 |
|
$0.30 |
|
$0.30 |
|